Ra Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing some of their medical products and clinical research.
The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.
“Additionally, inhibition of C5a activity has been shown to improve renal function and histopathological features associated with LN in animal models of the disease.” Read the following article
Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It provides pharmaceutical products for treatment of diseases of complement dysregulation. It utilizes small molecules and peptide to address pathological targets in the complement cascade. [Source: MarketWatch]
Company Website: http://rapharma.com